https://www.selleckchem.com/products/ms177.html
5 (47.3) vs. 51.9 (17.4) s, p = 0.0046) and flow time [86.9 (48.2) vs. 47.9 (19.6) s, p = 0.0052]. All patients showed absence of any significant adverse events. Significant improvement was seen in the AUA symptom score and uroflowmetry parameters and no patients required surgery during 24weeks post-treatment. It can be concluded that AALBEC is a safe and effective treatment for bulbar urethral stricture of 1 - 4cm length to improve the quality of life and the physiological function of urethra. Significant improvement was seen in the AUA
Curtir
Comentario
Compartilhar
